Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Immunotherapy plus chemotherapy improved overall survival in people with persistent, recurrent or metastatic cervical cancer.
Long-awaited results from the ANCHOR study suggest screening to detect precancerous lesions should be part of routine care.
A majority people with oral and throat cancer tested positive for DNA from high-risk HPV types in their saliva.
The antibody-drug conjugate Tivdak led to remission in 24% of cervical cancer patients.
Teens can receive the cancer-preventing HPV vaccine at the same time as their COVID-19 vaccine.
The vaccine protects against nine types of human papillomavirus, including those that cause cervical and anal cancer.
But results from the Mass General Brigham system also found that racial and economic disparities remain for some tests.
Prolonged delays in cancer screening for low-income women during the pandemic threaten to increase existing health disparities.
In a new initiative, the Grammy-winning artist advises Black women to protect their cervical health with annual Pap and HPV tests.
The early cancer is detected, the easier it is to treat.
More radical hysterectomies in women with early-stage cervical cancer are being performed by “open” surgery.
The COVID-19 pandemic has interrupted key health services for children and adolescents, including HPV vaccination for cancer prevention.
However, other malignancies caused by human papillomavirus, including anal and oral cancers, are on the rise.
Studies have shown an alarming drop in screenings—and more advanced cancer—during the COVID-19 pandemic.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.